VolitionRx Limited to Ring the New York Stock Exchange Closing Bell on Monday, March 13th at 4 pm Eastern Daylight Time
VolitionRx Limited Announces Full Fiscal Year 2016 Financial Results and Business Update
VolitionRx Limited to Present at the 29th Annual ROTH Conference
VolitionRx Limited Schedules Fourth Quarter and Full Year 2016 Earnings Conference Call and Business Update
A Logistics and Pathway Design Study for Volition's CE Marked NuQ(TM) Triage Test has been Commenced in the Capital Region of Denmark
VolitionRx Limited's Triage Test Results Validated in Prospective Trial
VolitionRx Limited to Attend the BTIG 2017 Medical Technology, Life Sciences, and Diagnostics Conference
VolitionRx Limited to Present at Source Capital Group's 2nd Annual Disruptive Growth & Healthcare Conference on February 15, 2017
VolitionRx Limited Strengthens Team with Key Appointment to Drive Sales and Trials in Asia
VolitionRx Limited's Novel Cancer Diagnostic Test Achieves CE Marking as it Prepares for Launch Across Europe
